Allogene Therapeutics Share Price (NASDAQ: ALLO)
$1.1
▲
0.03
(2.8%)
Last updated on
Check the interactive Allogene Therapeutics Stock chart to analyse performance
Allogene Therapeutics stock performance
as on August 16, 2025 at 1:29 AM IST
- Today's Low:$1.07Today's High:$1.20
2.73%
Downside
Day's Volatility :10.46%
Upside
7.95%
- 52 Weeks Low:$0.8652 Weeks High:$3.78
21.63%
Downside
52 Weeks Volatility :77.19%
Upside
70.9%
Allogene Therapeutics Stock Returns
Allogene Therapeutics, Inc. Key Stats
Check Allogene Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Allogene Therapeutics Stock including INR - Dollar returns
The Allogene Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Allogene Therapeutics investment value today
Current value as on today
₹45,719
Returns
Returns from Allogene Therapeutics Stock
Dollar Returns*
₹4,210 (+4.21%)
Indian investors sentiment towards Allogene Therapeutics Stock
Global Institutional Holdings in Allogene Therapeutics, Inc.
Name
Holdings %
Pfizer Inc
10.07%
TPG GP A, LLC
8.56%
BlackRock Inc
8.20%
Capital World Investors
5.61%
Darwin Global Management, Ltd.
4.78%
Citadel Advisors Llc
4.66%
Analyst Recommendation on Allogene Therapeutics Stock
Buy
73%Buy
26%Hold
0%Sell
Based on 23 Wall street analysts offering stock ratings for Allogene Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Allogene Therapeutics Share Price Target
What analysts predicted
Upside of 595.45%
Target:
$7.65
Current:
$1.10
Allogene Therapeutics share price target is $7.65, a slight Upside of 595.45% compared to current price of $1.10 as per analysts' prediction.
Allogene Therapeutics Stock Insights
Price Movement
In the last 6 months, ALLO stock has moved down by -46.1%Decreasing Revenue
Revenue is down for the last 2 quarters, 22.0K → -22.0K (in $), with an average decrease of 200.0% per quarterIncreasing Net Profit
Netprofit is up for the last 5 quarters, -66.35M → -50.94M (in $), with an average increase of 7.1% per quarterALLO vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 119.4%ALLO vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 101.2% return, outperforming this stock by 194.2%
Allogene Therapeutics Technicals Summary
Sell
Neutral
Buy
Allogene Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Allogene Therapeutics, Inc. Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -12.0% | -61.27% | -58.49% | -92.84% | -97.03% |
 | 7.02% | -14.62% | -51.49% | -7.08% | -6.14% |
 | 9.17% | 35.05% | 67.05% | 80.83% | 38.63% |
 | -14.57% | -15.0% | -19.51% | 33.48% | 44.78% |
 | 40.09% | 79.61% | 63.59% | 100.95% | 220.92% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.05 | -0.6 | -0.29 | NA | 1.99 |
| 14.03 | 14.03 | 1.14 | 39.47 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.43 | -0.05 | -0.01 | NA | 34.32 |
| 27.78 | 27.78 | 0.58 | 18.05 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $234.0M | -97.03% | NA | 0.0% |
| Buy | $59.0B | -6.14% | 14.03 | 31.37% |
| NA | $37.5B | 38.63% | NA | -3.89% |
| Buy | $100.1B | 44.78% | 27.78 | 31.86% |
| Buy | $58.0B | 220.92% | NA | -12.96% |
About Allogene Therapeutics, Inc.
Key Management of Allogene Therapeutics, Inc.
Important FAQs about investing in ALLO Stock from India :
What is Allogene Therapeutics share price today?
Allogene Therapeutics share price today is $1.10 as on at the close of the market. Allogene Therapeutics share today touched a day high of $1.20 and a low of $1.07.
What is the 52 week high and 52 week low for Allogene Therapeutics share?
Allogene Therapeutics share touched a 52 week high of $3.78 and a 52 week low of $0.86. Allogene Therapeutics stock price today, is trending at $1.10, lower by 70.9% versus the 52 week high.
How to invest in Allogene Therapeutics Stock (ALLO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Allogene Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Allogene Therapeutics Shares that will get you 1.3636 shares as per Allogene Therapeutics share price of $1.10 per share as on August 16, 2025 at 1:29 AM IST.
What is the minimum amount required to buy Allogene Therapeutics Stock (ALLO) from India?
Indian investors can start investing in Allogene Therapeutics (ALLO) shares with as little as ₹87.492 or $1 (as of August 17, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Allogene Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 17, 2025).
Based on Allogene Therapeutics share’s latest price of $1.10 as on August 16, 2025 at 1:29 AM IST, you will get 9.0909 shares of Allogene Therapeutics. Learn more about
fractional shares .
What are the returns that Allogene Therapeutics has given to Indian investors in the last 5 years?
Allogene Therapeutics stock has given -97.03% share price returns and 17.06% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?
Discover More
Journey Medical Corp$6.92
-4.68%
- T-rex 2x Long Microsoft Daily Target Etf
$35.73
-1.19%
- Heidmar Maritime Holdings Co
$1.55
-0.64%
C&f Financial Corp$68.48
-1.67%
Flexshares Mstar Us Mkt Factors Tilt Etf$233.64
-0.18%
- Global X Purecap Msci En Etf
$24.89
+0.12%
Schwab International Dividend Equity Etf$28.25
+0.46%
Precipio Inc$14.70
-0.07%
First Trust Nasdaq Artificia$50.52
+0.08%